x
Filter:
Filters applied
- Accelerated Communications
- translationRemove translation filter
- RNA structureRemove RNA structure filter
Publication Date
Please choose a date range between 2020 and 2022.
Keyword
- (+) ssRNA1
- coronavirus1
- coronavirus disease 2019 (COVID-19)1
- dimethyl sulfate1
- DMS1
- elution volume1
- inhibitor1
- mRNA pseudoknot1
- National Heart, Lung, and Blood Institute1
- NHLBI1
- programmed -1 ribosomal frameshifting (-1 PRF)1
- RBS1
- ribosome-binding site1
- riboswitch1
- RNA1
- SAXS1
- SEC1
- selective 2'-hydroxyl acylation analyzed by primer extension1
- SHAPE1
- T-loop chimera1
- TLC1
- TYMV1
- V e1
JBC Communications
2 Results
- Accelerated CommunicationOpen Access
The bacterial yjdF riboswitch regulates translation through its tRNA-like fold
Journal of Biological ChemistryVol. 298Issue 6101934Published online: April 12, 2022- Robert J. Trachman III
- Luiz F.M. Passalacqua
- Adrian R. Ferré-D’Amaré
Cited in Scopus: 0Unlike most riboswitches, which have one cognate effector, the bacterial yjdF riboswitch binds to diverse azaaromatic compounds, only a subset of which cause it to activate translation. We examined the yjdF aptamer domain by small-angle X-ray scattering and found that in the presence of activating ligands, the RNA adopts an overall shape similar to that of tRNA. Sequence analyses suggested that the yjdF aptamer is a homolog of tRNALys, and that two of the conserved loops of the riboswitch are equivalent to the D-loop and T-loop of tRNA, associating to form an elbow-like tertiary interaction. - Accelerated CommunicationsOpen Access
Structural and functional conservation of the programmed −1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2)
Journal of Biological ChemistryVol. 295Issue 31p10741–10748Published online: June 22, 2020- Jamie A. Kelly
- Alexandra N. Olson
- Krishna Neupane
- Sneha Munshi
- Josue San Emeterio
- Lois Pollack
- and others
Cited in Scopus: 91Approximately 17 years after the severe acute respiratory syndrome coronavirus (SARS-CoV) epidemic, the world is currently facing the COVID-19 pandemic caused by SARS corona virus 2 (SARS-CoV-2). According to the most optimistic projections, it will take more than a year to develop a vaccine, so the best short-term strategy may lie in identifying virus-specific targets for small molecule–based interventions. All coronaviruses utilize a molecular mechanism called programmed −1 ribosomal frameshift (−1 PRF) to control the relative expression of their proteins.